2:30 pm – 4:30 pm
Dr. Everett Chalmers Hospital – CHAT THEATRE
700 Priestman Street, Fredericton, NB, E3B 5N5

The University of New Brunswick and St. Thomas University are cohosting a presentation by Dr. Shelley Turner entitled “The Use of Cannabinoid-Based Medicine in Clinical Practice” on September 28 from 2:30 pm to 4:30 pm at the Chat Theatre, Dr. Everett Chalmers Hospital.

In this in-service presentation, Dr. Turner will discuss the evolution of her addiction medicine practice incorporating cannabinoid-based medicines to support those living with substance use/misuse, chronic non-cancer pain, insomnia and anxiety. During her one-hour presentation, she will provide an overview of the science, cases and research, both current and upcoming. Dr. Turner will be available for questions for up to one hour following the presentation.

Please RSVP as seats are limited (walk-ins will be welcome if seats remain, but priority will be given to those who have registered): https://forms.office.com/r/UTx34W91fY

About the speaker:

Dr. Shelley Turner, MD CCFP FCFP is a proud member of the Pimicikamak First Nation in Cross Lake, Manitoba. She is regarded as a trailblazer in the medical cannabis community specializing in cannabinoid-based medicine. She received both her MD and Rural Family Medicine Residency from McMaster University. Dr. Turner is committed to clinical research and is an Assistant Professor, Rady School of Medicine, Department of family Medicine, University of Manitoba. Her Addiction Medicine focused practice serves vulnerable, rural and remote populations. 

Dr. Turner is also the medical advisor for a new Harm Reduction Pilot Program in Natoaganeg (Eel Ground) First Nation led by Gitpo Spirit Lodge. The project incorporates Cannabinoid-Based Medicine for individuals currently receiving Opioid Agonist Therapy (OAT) such as methadone, buprenorphine/naloxone and buprenorphine. Dr. Turner is delivering the Cannabinoid-Based Medicine programming for participants and leads the project’s medical clinical research team. Funding for the Pilot Program is provided by Health Canada's Substance Use and Addictions Program.